News & Blog

Tag Archives: FDA

Cancer Research Takes the National Spotlight This Week

Two announcements this week thrust the importance of funding biomedical research into the national spotlight, yet again. This Wednesday, Vice President Joe Biden stepped in front of a podium in the White House Rose Garden and made a long anticipated announcement: his decision regarding a presidential bid. However, after the Vice President revealed his plan […]

Brain Tumor Groups Come Together for New Imaging Effort

When an athlete injures their knee, ankle, shoulder, etc. they will often need to go for an “MRI” to determine the extent of the damage done to the affected area. And in most cases the MRI will be able to diagnose the issues with relative ease, accuracy and expediency. Most Americans are familiar with MRIs […]

Brain Tumor News From the 2015 American Society for Clinical Oncology Meeting

From May 29 – June 2, National Brain Tumor Society Research and Scientific Operations staff attended the 2015 American Society of Clinical Oncology (ASCO) Annual Meeting, one of the most important cancer research meetings of the year. Each year, we attend ASCO to learn about the latest research on emerging new treatments and get updates on […]

Share